Prostate cancer mortality and costs of prostate surgical procedures in the Brazilian public health system

Porcacchia, Allan Saj; Pires, Gabriel Natan; Ortiz, Valdemar; Andersen, Mônica Levy; Tufik, Sérgio

doi:10.1590/s1677-5538.ibju.2021.0781

Cited by 2 publications

(2 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Prostate cancer (PCa) is a significant cause of global cancer-related mortality, and South America is no exception ( 1 , 2 ). Despite advancements in adopting active surveillance for low-risk PCa, which has significantly decreased overtreatment, radical treatments are the only guideline-approved active treatment modalities.…”

Section: Introductionmentioning

confidence: 99%

Focal Therapy: Overcoming Barriers for Advances in Prostate Cancer Treatment in South America

Ezequiel,

Marcelo,

Polascik

et al. 2024

Int. braz j urol.

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Focal Therapy: Overcoming Barriers for Advances in Prostate Cancer Treatment in South America

Ezequiel,

Marcelo,

Polascik

et al. 2024

Int. braz j urol.

View full text Add to dashboard Cite

“…Prostate cancer has a rapid progression and is prone to metastasis. Most patients are already in the middle and advanced stages when it is detected, significantly affecting their physical and mental health (2). Currently, surgery is the primary clinical treatment for prostate cancer, and postoperative radiotherapy and chemotherapy are also essential; however, the side effects of radiotherapy and chemotherapy drugs greatly reduce patients' quality of life.…”

Section: Introductionmentioning

confidence: 99%

Effects of brucine on mitochondrial apoptosis and expression of HSP70 in prostate cancer cells

Yan¹,

Zeng²,

Qin³

et al. 2022

Transl Cancer Res TCR

View full text Add to dashboard Cite

Background: Most prostate cancer patients are already in the middle/advanced stages of the disease at the time of detection. Whether brucine can regulate apoptosis in prostate cancer cells through the expression of heat shock protein 70 (HSP70) has not been reported. We preliminarily investigated the effects of brucine on the mitochondrial apoptosis and HSP70 expression of prostate cancer cells and analyzed brucine's possible mechanisms in the hope of providing an experimental basis for its clinical application. Methods:The effect of brucine on the activity of PC-3 cells was determined by the methodology of tetrazolium (MTT) assay method. The effect of brucine on apoptosis was measured by Hoechst 33258 staining and flow cytometry, and western blotting was used to detect the expression levels of the apoptosisrelated heat shock protein 70 (HSP70), anti-apoptotic protease activating factor 1 (Apaf-1) and anti-cysteine protease-3 (caspase-3).Results: At 24 and 48 h, the activity of human prostate cancer PC-3 cells in the low, medium, and high dose brucine groups was significantly lower than that of the control group, with a dose-dependent difference (P<0.01). The nuclei of the control group fluoresced uniformly with intact nuclei, whereas the nuclei of the brucine group appeared crinkled, and dense granular masses of strong blue fluorescence were visible. The apoptosis rate of human prostate cancer PC-3 cells in the low, medium, and high dose brucine groups was significantly higher than that in the control group (P<0.01) and was dose-dependent. The expression levels of the HSP70 protein in the human prostate cancer PC-3 cells in the low, medium, and high dose brucine groups were significantly lower than those in the control group, while the expression levels of the Apaf-1 and caspase-3 proteins were significantly higher than those in the control group (P<0.01) and showed a dosedependent relationship.Conclusions: Brucine downregulated HSP70 expression in human prostate cancer PC-3 cells and inhibited the mitochondrial apoptotic signaling pathway, thus acting as an anti-apoptotic agent.

show abstract

Prostate cancer mortality and costs of prostate surgical procedures in the Brazilian public health system

Cited by 2 publications

References 15 publications

Focal Therapy: Overcoming Barriers for Advances in Prostate Cancer Treatment in South America

Focal Therapy: Overcoming Barriers for Advances in Prostate Cancer Treatment in South America

Effects of brucine on mitochondrial apoptosis and expression of HSP70 in prostate cancer cells

Contact Info

Product

Resources

About